檢索結果 - Jenny E. Blau
- Showing 1 - 10 results of 10
-
1
Adverse effects of SGLT2 inhibitors on bone health 由 Jenny E. Blau, Simeon I. Taylor
出版 2018Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study 由 Jenny E. Blau, Viviana Bauman, Ellen M. Conway, Paolo Piaggi, Mary Walter, Elizabeth C. Wright, Shanna Bernstein, Amber B. Courville, Michael T. Collins, Kristina I. Rother, Simeon I. Taylor
出版 2018Artigo -
9
The greater impact of <scp><i>PNPLA3</i></scp> polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study 由 Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Ola Fjellström, Jenny E. Blau, Björn Carlsson, Takeshi Okanoue, Yoshito Itoh
出版 2023Artigo -
10
Genotype-phenotype correlation in multiple endocrine neoplasia type 1 由 CHARLITA WORTHY, Rana Tora, Chandra N. Uttarkar, James Welch, Lynn S. Bliss, Craig Cochran, Anisha Ninan, Sheila Kumar, Stephen A. Wank, Sungyoung Auh, Lee S. Weinstein, William F. Simonds, Sunita Agarwal, Jenny E. Blau, Smita Jha
出版 2025Artigo
相關主題
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Type 2 diabetes
Adverse effect
Canagliflozin
Dapagliflozin
Insulin
Chemistry
Diabetic ketoacidosis
Intensive care medicine
Ketoacidosis
Pharmacology
Type 1 diabetes
Alternative medicine
Biochemistry
Biology
Calcium
Empagliflozin
Food science
Gene
Genetics
Genotype
Parathyroid hormone
Pathology
Placebo
Acidosis
Adverse Event Reporting System
Alcoholic liver disease